#SEMO
2 articles
From Population Averages to Network Gaps: The Methodological Shift Behind the SEMO Patent
On May 8, 2026, the China National Intellectual Property Administration granted the invention patent Method, System and Application for Generating Compound Intervention Schemes Based on Pre-trained Models (CN117766054B). This patent corresponds to our technical exploration around SEMO: how to put compounds, protein-protein interaction networks, individual omics data, and intervention scheme generation into a computable framework. I prefer to understand it as a methodological shift from checking whether an indicator is below the average to examining whether there exists an intervenable gap within the individual network.
2026-05-10
DeepVime (1): In Vivo Efficacy Profiling of Drugs and Foods Based on Saliva Samples
DeepVime technology for in vivo efficacy profiling, detecting the effects and mechanisms of food-drug products through saliva DNA methylation changes.
2025-06-15